8/7/2023 0 Comments Dr. daniel schwartzHillblom Foundation, and many of his patients. He is grateful for the research support he has received from the NIH, Research Prevent Blindness, the Pritzker Family Fund, the Hellman Foundation, the Larry L. Schwartz is board certified in cardiovascular disease, echocardiography and vascular imaging. He completed a fellowship in cardiovascular disease at the University of Maryland School of Medicine. Schwartz’s current efforts are directed at developing novel therapies for age-related macular degeneration and myopic macular degeneration. Daniel Schwartz, M.D., F.A.C.C., R.P.V.I., received his medical degree from The George Washington University School of Medicine. OCT angiography is playing an increasingly important role in diagnosis and management of age-related macular degeneration, diabetic retinopathy, and other common retinovascular diseases. Scott Fraser and Jeff Fingler, he co-invented OCT angiography, a non-invasive means of imaging the retinal and choroidal vasculature. FDA Approved in 2017, it optimizes vision without spectacles for patients who have had cataract surgery. Robert Grubbs and Julia Kornfield at Caltech, he co-invented the Light Adjustable Lens, an intraocular lens whose power can be adjusted non-invasively using light during the post-operative period. His research focuses on developing new therapies and diagnostics for eye disease. He serves as Director of the Retina Division at the San Francisco VA Medical Center. Schwartz joined the UCSF Department of Ophthalmology in 1990. (BOOK)." SpringerBriefs in Child Health.Dr. Schwartz DD, Axelrad MA "Healthcare partnerships for promoting pediatric adherence: promoting collaborative management for pediatric chronic illness care."Practical Strategies to Enhance Executive Functioning and Strengthen Diabetes Management across the Lifespan." Current Diabetes Reports. Wasserman RM, Hilliard ME, Schwartz DD, Anderson BJ.Hansen JA, Weissbrod C, Schwartz DD, Taylor WP " Paternal involvement in pediatric Type 1 diabetes: Fathers' and mothers' psychological functioning and disease management." Fam Syst Health.Axelrad ME, Schwartz DD, Katzenstein JM, Hopkins E, Gripp KW " Neurocognitive, adaptive, and behavioral functioning of individuals with Costello syndrome: A review." Am J Med Genet C Semin Med Genet."Neurocognitive outcomes in pediatric diabetes: a developmental perspective." Current Diabetes Reports. Schwartz DD, Wasserman R, Powell PW, Axelrad ME."Neurocognitive functioning in children and adolescents at the time of Type 1 diabetes diagnosis: Associations with glycemic control one year after diagnosis." Diabetes Care. Antonini TN, Kerne V, Axelrad ME, Karaviti LP, Schwartz DD "Neurocognitive Functioning in a Young Adolescent with DK Phocomelia Syndrome." Am J Med Genet A.Axelrad ME, Schwartz DD, Fehlis JE, Hopkins E, Stabley DL, Sol-Church K, Gripp KW " Longitudinal course of cognitive, adaptive, and behavioral characteristics in Costello syndrome." Am.Schwartz DD, Cline VD, Axelrad ME, Anderson BJ " Feasibility, acceptability, and predictive validity of a psychosocial screening program for children and youth newly diagnosed with type 1 diabetes." Diabetes Care.Schwartz DD, Cline VD, Hansen JA, Axelrad ME, Anderson BJ " Early risk factors for nonadherence in pediatric type 1 diabetes: a review of the recent literature." Curr Diabetes Rev."Diabetes in Ethnic Minority Youth: Disparate Burden and Intervention Approaches." Curr Diabetes Rev.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |